Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Identification, isolation and characterization of human LGR5-positive colon adenoma cells.

Dame MK, Attili D, McClintock SD, Dedhia PH, Ouillette P, Hardt O, Chin AM, Xue X, Laliberte J, Katz EL, Newsome GM, Hill DR, Miller AJ, Tsai YH, Agorku D, Altheim CH, Bosio A, Simon B, Samuelson LC, Stoerker JA, Appelman HD, Varani J, Wicha MS, Brenner DE, Shah YM, Spence JR, Colacino JA.

Development. 2018 Mar 14;145(6). pii: dev153049. doi: 10.1242/dev.153049.

2.

MDI 301 suppresses myeloid leukemia cell growth in vitro and in vivo without the toxicity associated with all-trans retinoic acid therapy.

Aslam MN, McClintock S, Khan SP, Perone P, Allen R, Ouillette PD, Dame MK, Cheng JX, Kunkel SL, Varani J.

Anticancer Drugs. 2015 Aug;26(7):763-73. doi: 10.1097/CAD.0000000000000248.

PMID:
26010252
3.

Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia.

Parkin B, Ouillette P, Yildiz M, Saiya-Cork K, Shedden K, Malek SN.

Clin Cancer Res. 2015 May 1;21(9):2045-56. doi: 10.1158/1078-0432.CCR-14-0921. Epub 2015 Feb 4.

4.

Activating STAT6 mutations in follicular lymphoma.

Yildiz M, Li H, Bernard D, Amin NA, Ouillette P, Jones S, Saiya-Cork K, Parkin B, Jacobi K, Shedden K, Wang S, Chang AE, Kaminski MS, Malek SN.

Blood. 2015 Jan 22;125(4):668-79. doi: 10.1182/blood-2014-06-582650. Epub 2014 Nov 26.

5.

Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

Li H, Kaminski MS, Li Y, Yildiz M, Ouillette P, Jones S, Fox H, Jacobi K, Saiya-Cork K, Bixby D, Lebovic D, Roulston D, Shedden K, Sabel M, Marentette L, Cimmino V, Chang AE, Malek SN.

Blood. 2014 Mar 6;123(10):1487-98. doi: 10.1182/blood-2013-05-500264. Epub 2014 Jan 16.

6.

Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia.

Cao F, Townsend EC, Karatas H, Xu J, Li L, Lee S, Liu L, Chen Y, Ouillette P, Zhu J, Hess JL, Atadja P, Lei M, Qin ZS, Malek S, Wang S, Dou Y.

Mol Cell. 2014 Jan 23;53(2):247-61. doi: 10.1016/j.molcel.2013.12.001. Epub 2014 Jan 2.

7.

Genetics of follicular lymphoma transformation.

Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, Ouillette P, Trifonov V, Rossi D, Tabbò F, Ponzoni M, Chadburn A, Murty VV, Bhagat G, Gaidano G, Inghirami G, Malek SN, Rabadan R, Dalla-Favera R.

Cell Rep. 2014 Jan 16;6(1):130-40. doi: 10.1016/j.celrep.2013.12.027. Epub 2014 Jan 2.

8.

Acquired genomic copy number aberrations in CLL.

Ouillette P, Malek S.

Adv Exp Med Biol. 2013;792:47-86. doi: 10.1007/978-1-4614-8051-8_3. Review.

PMID:
24014292
9.

Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.

Ouillette P, Saiya-Cork K, Seymour E, Li C, Shedden K, Malek SN.

Clin Cancer Res. 2013 Jun 1;19(11):2893-904. doi: 10.1158/1078-0432.CCR-13-0138. Epub 2013 Apr 25.

10.
11.

Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia.

Parkin B, Ouillette P, Li Y, Keller J, Lam C, Roulston D, Li C, Shedden K, Malek SN.

Blood. 2013 Jan 10;121(2):369-77. doi: 10.1182/blood-2012-04-427039. Epub 2012 Nov 21.

12.

Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.

Ouillette P, Li J, Shaknovich R, Li Y, Melnick A, Shedden K, Malek SN.

Genes Chromosomes Cancer. 2012 Dec;51(12):1125-32. doi: 10.1002/gcc.21997. Epub 2012 Sep 6.

13.

Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34.

Shedden K, Li Y, Ouillette P, Malek SN.

Leukemia. 2012 May;26(5):1108-10. doi: 10.1038/leu.2011.361. Epub 2011 Dec 20. No abstract available.

14.

Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.

Li M, Collins R, Jiao Y, Ouillette P, Bixby D, Erba H, Vogelstein B, Kinzler KW, Papadopoulos N, Malek SN.

Blood. 2011 Nov 24;118(22):5914-7. doi: 10.1182/blood-2011-05-356204. Epub 2011 Oct 11.

15.

The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.

Ouillette P, Collins R, Shakhan S, Li J, Li C, Shedden K, Malek SN.

Clin Cancer Res. 2011 Nov 1;17(21):6778-90. doi: 10.1158/1078-0432.CCR-11-0785. Epub 2011 Sep 2.

16.

Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.

Ouillette P, Collins R, Shakhan S, Li J, Peres E, Kujawski L, Talpaz M, Kaminski M, Li C, Shedden K, Malek SN.

Blood. 2011 Sep 15;118(11):3051-61. doi: 10.1182/blood-2010-12-327858. Epub 2011 Jul 27.

17.

Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia.

Zhang X, Reis M, Khoriaty R, Li Y, Ouillette P, Samayoa J, Carter H, Karchin R, Li M, Diaz LA Jr, Velculescu VE, Papadopoulos N, Kinzler KW, Vogelstein B, Malek SN.

Leukemia. 2011 Dec;25(12):1908-10. doi: 10.1038/leu.2011.163. Epub 2011 Jun 24. No abstract available.

18.

A pathobiological role of the insulin receptor in chronic lymphocytic leukemia.

Saiya-Cork K, Collins R, Parkin B, Ouillette P, Kuizon E, Kujawski L, Erba H, Campagnaro E, Shedden K, Kaminski M, Malek SN.

Clin Cancer Res. 2011 May 1;17(9):2679-92. doi: 10.1158/1078-0432.CCR-10-2058. Epub 2011 Feb 9.

19.

Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.

Parkin B, Erba H, Ouillette P, Roulston D, Purkayastha A, Karp J, Talpaz M, Kujawski L, Shakhan S, Li C, Shedden K, Malek SN.

Blood. 2010 Dec 2;116(23):4958-67. doi: 10.1182/blood-2010-01-266999. Epub 2010 Aug 20.

20.

NF1 inactivation in adult acute myelogenous leukemia.

Parkin B, Ouillette P, Wang Y, Liu Y, Wright W, Roulston D, Purkayastha A, Dressel A, Karp J, Bockenstedt P, Al-Zoubi A, Talpaz M, Kujawski L, Liu Y, Shedden K, Shakhan S, Li C, Erba H, Malek SN.

Clin Cancer Res. 2010 Aug 15;16(16):4135-47. doi: 10.1158/1078-0432.CCR-09-2639. Epub 2010 May 26.

21.

Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia.

Long J, Parkin B, Ouillette P, Bixby D, Shedden K, Erba H, Wang S, Malek SN.

Blood. 2010 Jul 8;116(1):71-80. doi: 10.1182/blood-2010-01-261628. Epub 2010 Apr 19.

22.

Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks.

Ouillette P, Fossum S, Parkin B, Ding L, Bockenstedt P, Al-Zoubi A, Shedden K, Malek SN.

Clin Cancer Res. 2010 Feb 1;16(3):835-47. doi: 10.1158/1078-0432.CCR-09-2534. Epub 2010 Jan 19.

23.

Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.

Kujawski L, Ouillette P, Erba H, Saddler C, Jakubowiak A, Kaminski M, Shedden K, Malek SN.

Blood. 2008 Sep 1;112(5):1993-2003. doi: 10.1182/blood-2007-07-099432. Epub 2008 Apr 24.

24.

Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.

Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN.

Cancer Res. 2008 Feb 15;68(4):1012-21. doi: 10.1158/0008-5472.CAN-07-3105.

25.

Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia.

Saddler C, Ouillette P, Kujawski L, Shangary S, Talpaz M, Kaminski M, Erba H, Shedden K, Wang S, Malek SN.

Blood. 2008 Feb 1;111(3):1584-93. Epub 2007 Oct 30.

26.

Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis.

Ross CW, Ouillette PD, Saddler CM, Shedden KA, Malek SN.

Clin Cancer Res. 2007 Aug 15;13(16):4777-85.

27.

Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers.

McClure RF, Kaur P, Pagel E, Ouillette PD, Holtegaard CE, Treptow CL, Kurtin PJ.

Leukemia. 2006 Jan;20(1):176-9. No abstract available.

PMID:
16307010

Supplemental Content

Loading ...
Support Center